Watch the interview with Saniona

Saniona’s CEO Thomas Feldthus and incoming Chairman of the Board John Haurum participated in a live interview at BioStock’s studio, where they answered investors' questions. The discussion covered topics such as the prospects for a potential approval of tesofensine in Mexico, the company’s view on expansion in Brazil and South Korea, and the strategically important deal with Acadia. Additionally, they provided insights into upcoming milestones in Saniona’s broader pipeline.

Watch Thomas Feldthus and John Haurum respond to viewers’ questions below.

2025 Goals & Strategy: Saniona’s Plan Moving Forward | Live Q&A with BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/